tility of intra-abdominal pressure and clinical ultrasound for guiding diuretic treatment in patients with acute heart failure - PI23/00797

Fundacion Instituto De Investigacion Sanitaria Aragon0 个研究点目标入组 168 人开始时间: 2024年5月21日最近更新: 2024年8月21日

适应症

试验速览

暂无简介。

•Men or women over 18 years of age, Diagnosis of HF based on the latest HF guidelines published in 2022, NT-proBNP > 1000 pg/mL or BNP > 250 pg/mL, Bladder catheterization in order to perform intra-abdominal pressure measurement, Intravascular or mixed pattern of congestion, defined as the presence of one or more clinical signs of congestion (edema, ascites and/or pleural effusion), Signature of the informed consent

•Patient with stay in the internal medicine department > 24 hours, Systolic blood pressure at admission < 100 mmHg, Heart rate at admission > 170 beats per minute (bpm), Cardiogenic shock, Acute myocardial ischemia, Patients receiving renal replacement therapy (ultrafiltration or peritoneal dialysis)., Patients whose origin is the Intensive Care Unit, Renal transplant recipients, Serum hemoglobin < 9 g/dL, Pregnancy or lactation, Previous history of hypersensitivity to hydrochlorothiazide or furosemide., Patients with recent cardiac surgery (last year) or cardiac transplant recipients, Need for inotropic support to maintain adequate cardiac and/or renal output, Absence of sufficient clinical congestion (ADVOR score = 0 at the time of randomization), Patient refusal to participate in the clinical trial, Inability or contraindication to bladder catheterization

发起方

Fundacion Instituto De Investigacion Sanitaria Aragon